Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-26
DOI
10.1038/s41598-022-22647-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
- (2022) Niklas Mattsson-Carlgren et al. NEUROLOGY
- Update on CSF Biomarkers in Parkinson’s Disease
- (2022) Eun Hae Kwon et al. Biomolecules
- Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
- (2022) Denis S. Smirnov et al. ACTA NEUROPATHOLOGICA
- Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
- (2021) Rik Ossenkoppele et al. Alzheimers & Dementia
- Temporal trajectory of biofluid markers in Parkinson’s disease
- (2021) Min Seok Baek et al. Scientific Reports
- TDP-43 Pathology in Alzheimer’s Disease
- (2021) Axel Meneses et al. Molecular Neurodegeneration
- Structure of pathological TDP-43 filaments from ALS with FTLD
- (2021) Diana Arseni et al. NATURE
- Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
- (2020) Chun-Wei Chang et al. Frontiers in Neurology
- Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
- (2020) James D. Doecke et al. NEUROLOGY
- Clinical significance of fluid biomarkers in Alzheimer’s Disease
- (2020) Piotr Lewczuk et al. Pharmacological Reports
- ATN classification and clinical progression in subjective cognitive decline
- (2020) Jarith L. Ebenau et al. NEUROLOGY
- The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease
- (2020) Fubin Jiao et al. Frontiers in Aging Neuroscience
- The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
- (2020) Myungjin Jo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Impact of Amyloid-Beta Positivity with 18F-Florbetaben PET on Neuropsychological Aspects in Parkinson’s Disease Dementia
- (2020) Seunghee Na et al. Metabolites
- Plasma Total α-Synuclein and Neurofilament Light Chain: Clinical Validation for Discriminating Parkinson’s Disease from Normal Control
- (2020) Wei-Che Lin et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer’s disease
- (2020) Yao-Hsiang Shih et al. Nature Communications
- The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
- (2019) Britt A. Berning et al. Frontiers in Neuroscience
- α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities
- (2019) Parvez Alam et al. JOURNAL OF NEUROCHEMISTRY
- Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein
- (2019) Katsuya Araki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
- (2019) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Mechanisms of secretion and spreading of pathological tau protein
- (2019) Cecilia A. Brunello et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease
- (2019) Chih-Hao Chen et al. Journal of Parkinsons Disease
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
- (2018) Charlotte E. Teunissen et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Alzheimer disease pathology and the cerebrospinal fluid proteome
- (2018) Loïc Dayon et al. Alzheimers Research & Therapy
- Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
- (2018) Claudio Soto et al. NATURE NEUROSCIENCE
- Tau Pathology in Parkinson's Disease
- (2018) Xue Zhang et al. Frontiers in Neurology
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Frontotemporal Dementia
- (2017) Nicholas T. Olney et al. NEUROLOGIC CLINICS
- Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
- (2017) Shieh-Yueh Yang et al. Scientific Reports
- Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
- (2017) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
- (2017) Joakim Hertze et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of Conventional ELISA with Electrochemiluminescence Technology for Detection of Amyloid-β in Plasma
- (2017) Esther S. Oh et al. JOURNAL OF ALZHEIMERS DISEASE
- Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
- (2016) Jing L. Guo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
- (2016) Dagmar H. Hepp et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases
- (2016) S. A. Youssef et al. VETERINARY PATHOLOGY
- Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling
- (2016) Sunil S. Adav et al. Molecular Brain
- Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
- (2016) Fuyuki Kametani et al. Scientific Reports
- TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes
- (2015) Rachel H. Tan et al. BRAIN
- Familial Behavioral Variant Frontotemporal Dementia Associated With Astrocyte-Predominant Tauopathy
- (2015) Isidre Ferrer et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Role of TDP-43 in Alzheimer’s Disease
- (2015) Xiao-Long Chang et al. MOLECULAR NEUROBIOLOGY
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
- (2014) John F. Kellie et al. Scientific Reports
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
- (2013) Ming-Jang Chiu et al. HUMAN BRAIN MAPPING
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
- (2012) M.J. Chiu et al. Current Alzheimer Research
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- β-Amyloid triggers ALS-associated TDP-43 pathology in AD models
- (2011) Alexander M. Herman et al. BRAIN RESEARCH
- CSF biomarkers in neurodegenerative diseases
- (2011) Niklas Mattsson CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
- (2011) Hanna Rosenmann JOURNAL OF MOLECULAR NEUROSCIENCE
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Molecular mechanisms of neurodegeneration in Alzheimer's disease
- (2010) L. Crews et al. HUMAN MOLECULAR GENETICS
- Protein Misfolding and Aggregation in Parkinson's Disease
- (2009) Jeanne M.M. Tan et al. ANTIOXIDANTS & REDOX SIGNALING
- Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
- (2008) Masato Hasegawa et al. ANNALS OF NEUROLOGY
- The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia
- (2008) Ian RA Mackenzie et al. CURRENT OPINION IN NEUROLOGY
- Hyper-high-sensitivity wash-free magnetoreduction assay on biomolecules using high-Tc superconducting quantum interference devices
- (2008) J. J. Chieh et al. JOURNAL OF APPLIED PHYSICS
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More